The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Immune escape as a fundamental trait of cancer: focus on IDO
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,203
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“Indeed, challenging old assumptions that the therapeutic efficacy of chemotherapeutics is based on the efficiency of cancer cell killing, striking evidence was provided recently that efficacy depends on activation of Toll-like receptor TLR4 by ‘alarmin’ proteins that are released by cells killed by chemotherapy (Apeto…”
BackgroundThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Immunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Adaptive immunity maintains occult cancer in an equilibrium state
Koebel, C. M., Vermi, W., Swann, J. B., Zerafa, N., Rodig, S. J., Old, L. J., Smyth, M. J., & Schreiber, R. D. (2007) · Nature · doi:10.1038/nature06309 · Cited by 1,436
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M.-L., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,374
Munn, D. H., Sharma, M. D., Baban, B., Harding, H. P., Zhang, Y., Ron, D., & Mellor, A. L. (2005) · Immunity · doi:10.1016/j.immuni.2005.03.013 · Cited by 1,272
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,047
T cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Solid Cancers after Bone Marrow Transplantation
Curtis, R. E., Rowlings, P. A., Deeg, H. J., Shriner, D. A., Socié, G., Travis, L. B., Horowitz, M. M., Witherspoon, R. P., Hoover, R. N., Sobocinski, K. A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361301 · Cited by 965
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“, 2006) may serve an important role in epithelial tumorigenesis (Coussens et al., 1999; Muto et al., 2007; Soucek et al., 2007).”
BackgroundThe gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
Sharma, M. D., Baban, B., Chandler, P., Hou, D.-Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 792
Mast cells are essential intermediaries in regulatory T-cell tolerance
Lu, L.-F., Lind, E. F., Gondek, D. C., Bennett, K. A., Gleeson, M. W., Pino-Lagos, K., Scott, Z. A., Coyle, A. J., Reed, J. L., Van Snick, J., et al. (2006) · Nature · doi:10.1038/nature05010 · Cited by 751
CT Screening for Lung Cancer: Five-year Prospective Experience
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Mandrekar, S. J., Hillman, S. L., Sykes, A.-M., Aughenbaugh, G. L., Bungum, A. O., & Allen, K. L. (2005) · Radiology · doi:10.1148/radiol.2351041662 · Cited by 636
Hou, D.-Y., Muller, A. J., Sharma, M. D., DuHadaway, J., Banerjee, T., Johnson, M., Mellor, A. L., Prendergast, G. C., & Munn, D. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2925 · Cited by 586
Self-citationAPPL Proteins Link Rab5 to Nuclear Signal Transduction via an Endosomal Compartment
Miaczynska, M., Christoforidis, S., Giner, A., Shevchenko, A., Uttenweiler-Joseph, S., Habermann, B., Wilm, M., Parton, R. G., & Zerial, M. (2004) · Cell · doi:10.1016/s0092-8674(04)00117-5 · Cited by 539
Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Swigart, L. B., & Evan, G. I. (2007) · Nature Medicine · doi:10.1038/nm1649 · Cited by 507
Metz, R., DuHadaway, J. B., Kamasani, U., Laury-Kleintop, L., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1872 · Cited by 467
Self-citationMachiels, J.-P., Reilly, R. T., Emens, L. A., Ercolini, A. M., Lei, R. Y., Weintraub, D., Okoye, F. I., & Jaffee, E. M. (2001) · PubMed · Cited by 453
Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice
Ball, H. J., Sanchez-Perez, A., Weiser, S., Austin, C. J. D., Astelbauer, F., Miu, J., McQuillan, J. A., Stocker, R., Jermiin, L. S., & Hunt, N. H. (2007) · Gene · doi:10.1016/j.gene.2007.04.010 · Cited by 434
Mellor, A. L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D., & Munn, D. H. (2001) · Nature Immunology · doi:10.1038/83183 · Cited by 423
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Colombo, M. P., & Piconese, S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2250 · Cited by 407
Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S., Durelli, I., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036863 · Cited by 396
Popovic, P. J., Zeh, H. J., & Ochoa, J. B. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1681s · Cited by 391
BIN1 is a novel MYC–interacting protein with features of a tumour suppressor
Sakamuro, D., Elliott, K. J., Wechsler-Reya, R., & Prendergast, G. C. (1996) · Nature Genetics · doi:10.1038/ng0996-69 · Cited by 387
Self-citationMyc influences global chromatin structure
Knoepfler, P. S., Zhang, X., Cheng, P. F., Gafken, P. R., McMahon, S. B., & Eisenman, R. N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601152 · Cited by 383
Indoleamine 2,3‐dioxygenase contributes to tumor cell evasion of T cell‐mediated rejection
Friberg, M., Jennings, R., Alsarraj, M., Dessureault, S., Cantor, A., Extermann, M., Mellor, A. L., Munn, D. H., & Antonia, S. J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10645 · Cited by 365
SOME VIRUS ISOLATIONS FROM COMMON COLDS
Tyrrell, D. A. J., & Parsons, R. (1960) · The Lancet · doi:10.1016/s0140-6736(60)90168-9 · Cited by 337
Creating immune privilege: active local suppression that benefits friends, but protects foes
Mellor, A. L., & Munn, D. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2233 · Cited by 327
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy
Grohmann, U., Volpi, C., Fallarino, F., Bozza, S., Bianchi, R., Vacca, C., Orabona, C., Belladonna, M. L., Ayroldi, E., Nocentini, G., et al. (2007) · Nature Medicine · doi:10.1038/nm1563 · Cited by 318
Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro
Blank, C., Kuball, J., Voelkl, S., Wiendl, H., Becker, B., Walter, B., Majdic, O., Gajewski, T. F., Theobald, M., Andreesen, R., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21775 · Cited by 297
Mellor, A. L. (2004) · International Immunology · doi:10.1093/intimm/dxh140 · Cited by 288
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
Muller, A. J., & Scherle, P. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1929 · Cited by 262
The BAR Domain Proteins: Molding Membranes in Fission, Fusion, and Phagy
Ren, G., Vajjhala, P., Lee, J. S., Winsor, B., & Munn, A. L. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.37-120.2006 · Cited by 213
Ge, K., DuHadaway, J., Du, W., Herlyn, M., Rodeck, U., & Prendergast, G. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9689 · Cited by 195
Self-citationStructure−Activity Study of Brassinin Derivatives as Indoleamine 2,3-Dioxygenase Inhibitors
Gaspari, P., Banerjee, T., Malachowski, W. P., Muller, A. J., Prendergast, G. C., DuHadaway, J., Bennett, S., & Donovan, A. M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0508888 · Cited by 182
Self-citationXu, Q. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg786 · Cited by 176
Banerjee, T., DuHadaway, J. B., Gaspari, P., Sutanto-Ward, E., Munn, D. H., Mellor, A. L., Malachowski, W. P., Prendergast, G. C., & Muller, A. J. (2008) · Oncogene · doi:10.1038/sj.onc.1210939 · Cited by 175
Self-citationSystemic application of CpG‐rich DNA suppresses adaptive T cell immunity via induction of IDO
Wingender, G., Garbi, N., Schumak, B., Jüngerkes, F., Endl, E., von Bubnoff, D., Steitz, J., Striegler, J., Moldenhauer, G., Tüting, T., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535602 · Cited by 170
Cytoplasmic transport of Stat3 by receptor‐mediated endocytosis
Bild, A. H., Turkson, J., & Jove, R. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf351 · Cited by 153
Indoleamine 2,3-Dioxygenase in Immune Suppression and Cancer
Muller, A. J., & Prendergast, G. C. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006896 · Cited by 148
Self-citationBin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms
Elliott, K., Sakamuro, D., Basu, A., Du, W., Wunner, W. H., Staller, P., Gaubatz, S., Zhang, H., Prochownik, E. V., Eilers, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202670 · Cited by 126
Self-citationMuller, A. J., Malachowski, W. P., & Prendergast, G. C. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.4.831 · Cited by 115
Self-citationThe c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program
Elliott, K., Ge, K., Du, W., & Prendergast, G. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203681 · Cited by 106
Self-citationCancer Immunologists and Cancer Biologists: Why We Didn't Talk Then but Need to Now
Prendergast, G. C., & Jaffee, E. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4626 · Cited by 102
Self-citationLoss of heterozygosity and tumor suppressor activity ofBin1 in prostate carcinoma
Ge, K., Minhas, F., DuHadaway, J. B., Mao, N.-C., Wilson, D. M., Buccafusca, R., Sakamuro, D., Nelson, P. S., Malkowicz, S. B., Tomaszewski, J., et al. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000415)86:2<155::aid-ijc2>3.0.co;2-m · Cited by 97
Self-citationGe, K., DuHadaway, J. B., Sakamuro, D., Wechsler‐Reya, R. J., Reynolds, C. A., & Prendergast, G. C. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3<376::aid-ijc14>3.0.co;2-1 · Cited by 92
Self-citationTRYPTOPHAN METABOLISM IN CARCINOMA OF THE BREAST
ROSE, D. (1967) · The Lancet · doi:10.1016/s0140-6736(67)91301-3 · Cited by 73
Bin1 mediates apoptosis by c-Myc in transformed primary cells.
DuHadaway, J. B., Sakamuro, D., Ewert, D. L., & Prendergast, G. C. (2001) · PubMed · Cited by 73
Self-citationBin1 Ablation Increases Susceptibility to Cancer during Aging, Particularly Lung Cancer
Chang, M. Y., Boulden, J., Katz, J. B., Wang, L., Meyer, T. J., Soler, A. P., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1100 · Cited by 67
Self-citationTajiri, T., Liu, X., Thompson, P. M., Tanaka, S., Suita, S., Zhao, H., Maris, J. M., Prendergast, G. C., & Hogarty, M. D. (2003) · PubMed · Cited by 61
Self-citationRoy, M., Xu, Q., & Lee, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki792 · Cited by 57
TGF-beta and CD4+CD25+ Regulatory T cells
Huber, S., & Schramm, C. (2006) · Frontiers in bioscience · doi:10.2741/1859 · Cited by 48
Bin1 Ablation in Mammary Gland Delays Tissue Remodeling and Drives Cancer Progression
Chang, M. Y., Boulden, J., Sutanto‐Ward, E., DuHadaway, J. B., Soler, A. P., Muller, A. J., & Prendergast, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2742 · Cited by 47
Self-citationGerm Line Polymorphism in Metastatic Progression
Hunter, K. W., & Crawford, N. P. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3705 · Cited by 47
c‐MYC Impairs Immunogenicity of Human B Cells
Schlee, M., Schuhmacher, M., Hölzel, M., Laux, G., & Bornkamm, G. W. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(06)97007-9 · Cited by 32
Routhier, E., Donover, P. S., & Prendergast, G. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206162 · Cited by 30
Self-citationMuller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto‐Ward, E., & Prendergast, G. C. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.12.1232 · Cited by 25
Self-citationTransformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1
DuHadaway, J. B., Du, W., Donover, P. S., Baker, J. F., Liu, A., Sharp, D. M., Muller, A. J., & Prendergast, G. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206481 · Cited by 19
Self-citationBin1 Interacts with and Restrains the DNA End-Binding Protein Complex Ku
Ramalingam, A., Farmer, G. E., Stamato, T., & Prendergast, G. C. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4514 · Cited by 18
Self-citationGabrilovich, D. I. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780006850 · Cited by 18
Gabrilovich, D. I. (2007) · Current Cancer Drug Targets · doi:10.2174/1568009610707010001 · Cited by 17
Bin1 Homolog Hob1 Supports a Rad6-Set1 Pathway of Transcriptional Repression in Fission Yeast
Ramalingam, A., & Prendergast, G. C. (2007) · Cell Cycle · doi:10.4161/cc.6.13.4413 · Cited by 10
Self-citationMuto, S., Katsuki, M., & Horie, S. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00577.x · Cited by 6
Cited by
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Oxygen Activation and Radical Transformations in Heme Proteins and Metalloporphyrins
Huang, X., & Groves, J. T. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00373 · Cited by 1,037
Secondary metabolites of fungi from marine habitats
Rateb, M. E., & Ebel, R. (2011) · Natural Product Reports · doi:10.1039/c0np00061b · Cited by 645
The Two Faces of Interferon-γ in Cancer
Zaidi, M. R., & Merlino, G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0482 · Cited by 593
Discovery of IDO1 Inhibitors: From Bench to Bedside
Prendergast, G. C., Malachowski, W. P., DuHadaway, J. B., & Muller, A. J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2285 · Cited by 558
Self-citation
Metadata
- Authors
- Prendergast, G. C.
- Venue
- Oncogene
- Published
- 2008-03-03
- Volume
- 27
- Issue
- 28
- Pages
- 3889-3900
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2094530868
- Cited by
- 325
- References
- 78
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.